Rebecca Miksad, MD, MPH, MMSc, is a medical oncologist who serves as Chief Medical Officer at Color (www.color.com), the first 50-state Virtual Cancer Clinic. Clinically, she specializes in gastrointestinal oncology and serves as Associate Professor at Boston Medical Center, where she maintains an active clinical practice. She is an entrepreneur in AI, healthcare delivery innovation and cancer genetics. Her research expertise includes real-world evidence and data science in oncology, clinical trial methodology and patient-relevant endpoints, and health outcomes and decision science to advance equity in cancer care. A nationally recognized leader, Dr. Miksad has informed FDA guidances, serves on national committees, and lectures internationally. She previously directed gastrointestinal oncology and gastrointestinal oncology clinical trials at Beth Israel Deaconess Medical Center and established the first High-Risk Cancer Genetics clinic at Boston Medical Center; earlier at Flatiron Health, she helped set regulatory-grade quality standards for real-world data. Dr. Miksad earned her MD with honors in research from Cornell University, completed internal medicine residency at NewYork-Presbyterian Hospital (Cornell Campus), and a fellowship in Hematology and Medical Oncology at Beth Israel Deaconess Medical Center. She also holds an MPH in Clinical Effectiveness from the Harvard School of Public Health, an MMSc from Harvard Medical School, and completed post-doctoral training in the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training.
Associate Professor
2019 – present
Chief Medical Officer
2024 – present
Senior Medical Director
2017 – 2024
Assistant Professor
2007 – 2017
Medical School
2001
Residency
2001 – 2004
Fellowship
2004 – 2007